Progesterone deficiency states in women:
oral route of administration:
-
threatened abortion or prevention of habitual abortion due to progesterone deficiency; -infertility due to luteal insufficiency;
-premenstrual syndrome;
-
Disruption of the menstrual cycle due to impaired ovulation or anovulation; – fibrocystic mastopathy;
-period of menopausal transition;
-menopausal (replacement) hormone therapy (MHT) in peri- and postmenopausal women (in combination with estrogen-containing drugs).
vaginal route of administration:
-MH T in case of progesterone deficiency with non-functioning (absent) ovaries (egg donation);
-
prevention (prevention) of premature birth in women at risk (with shortening of the cervi and / or the presence of anamnestic data of premature birth and / or premature rupture of
the membranes);
-supporting the luteal phase during preparation for in vitro fertilization;
-support of the luteal phase in the spontaneous or induced menstrual cycle; – premature menopause;
-MH T (in combination with estrogencontaining drugs);
-infertility due to luteal insufficiency;
-
threatened abortion or prevention of habitual abortion due to progesterone deficiency.





